Atlas Trials

A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients

Clinical trial NCT03165955 · COMPLETED

Trial details

NCT number
NCT03165955
Sponsor
Health Hope Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breastcancer
Start date
2017-05-09
Primary completion
2018-11-22
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.